Navigation Links
Today's Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
Date:3/6/2013

call.com/PDLI030613.pdf">http://www.StockCall.com/PDLI030613.pdf

Dendreon Corporation traded in the range of $5.61 and $5.85 during Tuesday's trading session. It opened at $5.75 and closed at $5.70, down 0.35 percent. The stock is currently in a neutral mode and has its first resistance level at $5.80. Upon breaching this level, the company may go as high as $6.03. It traded 3.47 million shares and is above its 20-day moving average price. Its first support level is at $5.42. So far in 2013, the stock is up 7.75 percent. Be sure to read our latest technical research on DNDN by registering at

http://www.StockCall.com/DNDN030613.pdf

Despite the upward movement shown by broad market indices, Medivation Inc.'s stock finished 2.47 percent lower at $45.86, with volume up from daily average of 1.50 million to 3.64 million. The biotech company's stock is down so far in 2013 with a year-to-date decline at 10.36 percent. However, the stock currently shows a bearish trend which is further confirmed by the stock's MACD chart. Medivation has its first support level at $43.26. In the coming trading sessions, the stock is likely to go as high as $49.09. Sign up and read the complimentary report on MDVN at

http://www.StockCall.com/MDVN030613.pdf

ACADIA Pharmaceuticals Inc.'s stock rose mildly in its latest trading session. The stock closed 0.63 percent higher at $6.37 with 1.48 million share volume. Despite the mild upward movement, the stock is still up more than 36 percent for the year. In the past 52 weeks, the company's stock is up 300 percent. The stock currently has support at $6.28 level. The stock's MACD chart shows a neutral trend. ACADIA may face its first resistance level at $6.75. Upon breaching this level, the stock may go as high as $7.03. The free report on ACAD can be downloaded by signing up now at


SOURCE StockCall.com
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
2. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
5. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
6. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
7. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
8. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
11. Okuma America Chooses The Daniel Group To Provide Customer Service Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015   KaloBios Pharmaceuticals, ... company focused on developing innovative therapies to benefit patients ... on oncology, announced today that the U.S. Food and ... drug (IND) application for KB003, an anti-GM-CSF monoclonal antibody ... that the IND is now active. The ...
(Date:7/29/2015)... N.J. , July 29, 2015  Ortho-Clinical Diagnostics, ... five assays under development. The assays address a range ... kidney injury and cardiac troponin I. The scientific posters ... Clinical Chemistry Annual Meeting to be held July 26 ...   "Ortho Clinical Diagnostics is emerging stronger ...
(Date:7/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/zcrjfz/global ... "Global Neurostimulation Devices Market 2015" report to ... global neurostimulation devices market to grow at a ... The report, Global Neurostimulation Devices Market 2015-2019, ... analysis with inputs from industry experts. The report ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3Global Neurostimulation Devices Market 2015-2019 2
... , , SAN FRANCISCO, Sept. 23 ... today announced treatment of the first patient in a Phase ... cancer. Known as AFFIRM, the trial will evaluate the novel ... were previously treated with docetaxel-based chemotherapy. , , ...
... , , , , ... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that ... study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment ... , "We remain optimistic on this program and ...
Cached Medicine Technology:Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 2Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 3Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 4BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU 2BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU 3
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... as a sponsor, with its Topricin® Pain Relief and Healing Cream designated as ... firefighter-founded web-based organization that is actively addressing Line of Duty Deaths (LODD) and ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... According to ... suffering from drug or alcohol addiction and mental health disorders. Acu-detox may begin taking ... treating patients recovering from drug and alcohol addiction. Although acupuncture is not a new ...
(Date:7/29/2015)... ... July 29, 2015 , ... For the second year in ... in the list of the 50 fastest growing companies in Jacksonville. This annual list ... community. On July 16th, a team of Vast Bridges staffers were on hand to ...
(Date:7/29/2015)... Buckner, KY (PRWEB) , ... July 29, 2015 ... ... upcoming episode of American Farmer, airing fall of 2015 on RFD-TV. , Fastline ... segment, viewers will learn about Fastline.com, which contains the largest and freshest searchable ...
(Date:7/29/2015)... ... July 29, 2015 , ... Employee Fiduciary, LLC announces the launch of ... information, website, types of plans administered, years in business, and credentials of all Employee ... least one plan with Employee Fiduciary. A search can be done by zip code ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Vast Bridges Continues Its Swift Growth 2Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2
... KePRO,s Chief Medical Officer recognized for commitment to improving patient care ... ... February 6, 2009 -- Alice Stollenwerk Petrulis , MD, FACP, ... Committee. Dr. Petrulis, a nationally recognized leader in health care quality ...
... MASI ), the inventor of Pulse CO-Oximetry(TM) ... that its management is scheduled to present at the ... at The Ritz-Carlton, Laguna Niguel in Dana Point, California, ... A live audiocast of the presentation will be available ...
... Hospitalized Veterans Co-Sponsors Concert Series in Support of National ... As Valentines Day approaches, thousands of Americans will look ... and significant others. Whether it,s a thoughtful gift or ... time with loved ones and showing them your appreciation. ...
... the first South Florida,publication dedicated to providing expert advice ... men and women, will host its sold-out, first,annual 5K ... The Sports,Club/LA, as part of the series of events ... On February 8th, 2009, hundreds of runners and ...
... and little encouragement for kids to be otherwise, , , ... playing outside, children tend not to be physically active ... fact, the researchers found that 89 percent of so-called ... be sedentary at community-based preschool programs, as were more ...
... should not immediately order routine scans for low-back pain ... researchers in the Oregon Evidence-Based Practice Center at Oregon ... in this week,s edition of the The Lancet ... CT scans in patients with low-back pain but no ...
Cached Medicine News:Health News:Alice Stollenwerk Petrulis, MD, FACP, Appointed to NQF Care Coordination Committee 2Health News:Masimo to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference 2Health News:Free 'Valentines for Veterans Concerts' Honor Veterans Across the Country 2Health News:Free 'Valentines for Veterans Concerts' Honor Veterans Across the Country 3Health News:SOBeFiT Magazine Promotes its Launch With First Annual 5K Run+Walk & Fitness Festival in South Beach 2Health News:SOBeFiT Magazine Promotes its Launch With First Annual 5K Run+Walk & Fitness Festival in South Beach 3Health News:For Preschoolers, Even 'Play' Tends to Be Sedentary 2Health News:Routine scans for low-back pain do not improve outcomes 2Health News:Routine scans for low-back pain do not improve outcomes 3
Head-worn Loupe KF Titanium the teleloupe system is mounted on a special frame with straight temples and an elastic headband....
... magnification for advanced surgical procedures. Prismatic quality ... the highest magnification. 3.5x, 4.5x and 5.5x. ... rendition is ideal for surgical applications. Precision ... a superior image. The compact abd lightweight ...
... delivers higher magnification for advanced surgical procedures. ... even at the highest magnification. 3.5x, 4.5x ... precise color rendition is ideal for surgical ... coating produce a superior image. The compact ...
... The XL Advantage delivers higher magnification ... a crisp, true image, even at the ... to edge clarity and precise color rendition ... treated with an anti-reflective coating produce a ...
Medicine Products: